Recommendations and rationale for the treatment of pelvic inflammatory disease. - Wikidata - awgldk - TriplyDB

Recommendations and rationale for the treatment of pelvic inflammatory disease.

Recommendations and rationale for the treatment of pelvic inflammatory disease.

http://www.wikidata.org/entity/Q34155769

about

Mollicutes/HIV Coinfection and the Development of AIDS: Still Far from a Definitive Response Individualized medicine and the microbiome in reproductive tract Effective photodynamic therapy against microbial populations in human deep tissue abscess aspirates.Recent perspectives in the diagnosis and evidence-based treatment of Mycoplasma genitalium.Surveillance of antibiotic consumption using the "focus of infection" approach in 2 hospitals in Ujjain, India.Secretory leukocyte protease inhibitor binds to Neisseria gonorrhoeae outer membrane opacity protein and is bactericidal Human parasitic protozoan infection to infertility: a systematic review.Risk factors for adverse clinical outcomes in patients with tubo-ovarian abscess.

P2860

Q26740424-ADAC9FCF-69F5-4CCF-B2DD-6A68A6B6DD21 Q26999090-A1633BDB-7187-4BCE-847D-DAF5C2462BE1 Q31136103-D47C8183-4203-4E47-B57A-AF05D7B7C59B Q34269050-CEFF80C9-55CB-4C1A-A3F8-E07239DE8833 Q34310337-D0029EB8-F479-4F7A-95B2-86DE337D3889 Q36092095-EB1C2041-E4A1-4811-BD51-9EA6E30D46DD Q38634760-17828710-D90D-4E14-B4A2-862C83E8E39F Q41577929-24FE5D70-C5E2-48A9-964D-635CE5271417

P2860

Recommendations and rationale for the treatment of pelvic inflammatory disease.

http://www.wikidata.org/entity/Q34155769

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Recommendations and rationale for the treatment of pelvic inflammatory disease.

@ast

Recommendations and rationale for the treatment of pelvic inflammatory disease.

@en

Recommendations and rationale for the treatment of pelvic inflammatory disease.

@nl

type

label

Recommendations and rationale for the treatment of pelvic inflammatory disease.

@ast

Recommendations and rationale for the treatment of pelvic inflammatory disease.

@en

Recommendations and rationale for the treatment of pelvic inflammatory disease.

@nl

prefLabel

Recommendations and rationale for the treatment of pelvic inflammatory disease.

@ast

Recommendations and rationale for the treatment of pelvic inflammatory disease.

@en

Recommendations and rationale for the treatment of pelvic inflammatory disease.

@nl

P1433

Q34155769-0D5449F9-860B-46A1-AA7B-772949FC43B2

P1476

Q34155769-CA0DC878-3888-4254-BAEE-5B75024975D4

P2093

Q34155769-6E9C42E5-2531-4EF0-B0CD-DCFF05BF4DF7

Q34155769-BC047521-8410-44DE-BCB3-914DE8A5D168

Q34155769-D1ACA76B-E397-48B2-8542-0F2BB42C60C5

P2860

Q34155769-0A62E3CD-702C-48F0-AEA4-3E9ED3F8EE31

Q34155769-22DC5714-82F0-4516-9ABC-BEE026CFF86F

Q34155769-263AC0A0-9508-49E9-BB30-6F54DC11A42F

Q34155769-2C5610A9-DD08-43F8-8FA4-9A1065026181

Q34155769-3F216620-61E9-433C-A5CA-3FE2F3C5898B

Q34155769-4F1F6874-29D9-489B-A89F-461241E85134

Q34155769-59E0FC90-CD15-4ABB-860B-1EE8A9066C3E

Q34155769-630D8A00-0636-4671-91D2-00B0BB590F03

Q34155769-70F8942B-78E1-46EA-9E38-11E34DC006C6

Q34155769-7300AADE-3E6B-42ED-AA64-2B2B2AA1A536

P304

Q34155769-AA77EEA2-E895-41EE-B2B3-4E5D670A0C26

P31

Q34155769-24B6C7BE-C27C-4A8F-A408-F67AE0B9A860

Q34155769-51201588-31bb-4b2c-aeb6-73d8aad47d53

P356

Q34155769-85573DAD-82A2-4030-8EF1-D17F1BF31EF6

P433

Q34155769-9A786E48-190B-4853-B952-E4A68443600A

P478

Q34155769-FE382598-6B89-4809-98D9-F171FB1CA7D6

P577

Q34155769-6B699330-9E1F-4F95-9F47-5B69A428AD15

P5875

Q34155769-CA8FAB4A-98C0-4F55-BCF7-70F326B5452E

P698

Q34155769-74D0E502-D891-4612-8F65-DD56BC7C786D

P921

Q34155769-33C123DE-6E69-495E-9A66-3CD6AFC92362

P356

P1433

Expert Review of Anti-infective Therapy

P1476

Recommendations and rationale for the treatment of pelvic inflammatory disease.

@en

P2093

David E Soper

http://www.w3.org/2001/XMLSchema#string

Gweneth Lazenby

http://www.w3.org/2001/XMLSchema#string

Oluwatosin Jaiyeoba

http://www.w3.org/2001/XMLSchema#string

P2860

Persistence of Mycoplasma genitalium following azithromycin therapy

Mycoplasma genitalium -- an up-date.

Improvement in the clinical cure rate of outpatient management of pelvic inflammatory disease following a change in therapy.

Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease.

Comparative in vitro activities of azithromycin, Bay y 3118, levofloxacin, sparfloxacin, and 11 other oral antimicrobial agents against 194 aerobic and anaerobic bite wound isolates.

Detection of Mycoplasma genitalium in women with laparoscopically diagnosed acute salpingitis.

Azithromycin failure in Mycoplasma genitalium urethritis.

Epidemiology, pathogenesis and treatment of pelvic inflammatory disease.

Antibiotic therapy for acute pelvic inflammatory disease: the 2006 Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines.

Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: results of a multicentre, double blind, randomised trial.

P304

61-70

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERI.10.156

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49696388

http://www.w3.org/2001/XMLSchema#string

P698

21171878

http://www.w3.org/2001/XMLSchema#string

P921

pelvic inflammatory diseases